BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27416495)

  • 1. Understanding the Dynamic Convergence Phenomenon from the Perspective of Diversity and Persistence: A Cross-Sector Comparative Analysis between the United States and South Korea.
    Shim W; Kwon OJ; Moon YH; Kim KH
    PLoS One; 2016; 11(7):e0159249. PubMed ID: 27416495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents.
    Jiang Q; Luan C
    Global Health; 2018 Aug; 14(1):92. PubMed ID: 30165885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of collaborative innovation on ICT-based technological convergence: A patent-based analysis.
    Hwang I
    PLoS One; 2020; 15(2):e0228616. PubMed ID: 32017795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of research tool patents on biotechnology innovation in a developing country: a case study of South Korea.
    Kang KN; Ryu TK; Lee YS
    BMC Biotechnol; 2009 Mar; 9():25. PubMed ID: 19321013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of technology convergence networks in Korea: Characteristics of temporal changes in R&D according to institution type.
    Choi JY; Jeong S; Jung JK
    PLoS One; 2018; 13(2):e0192195. PubMed ID: 29420574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food-pharma convergence in medical nutrition- best of both worlds?
    Weenen TC; Ramezanpour B; Pronker ES; Commandeur H; Claassen E
    PLoS One; 2013; 8(12):e82609. PubMed ID: 24358214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entropy and gravity concepts as new methodological indexes to investigate technological convergence: patent network-based approach.
    Cho Y; Kim M
    PLoS One; 2014; 9(6):e98009. PubMed ID: 24914959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue Vaccines: A Perspective from the Point of View of Intellectual Property.
    da Veiga CP; da Veiga CR; Del Corso JM; da Silva WV
    Int J Environ Res Public Health; 2015 Aug; 12(8):9454-74. PubMed ID: 26274968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of technological competence and operations efficiency in the defense industry: The strategic planning of South Korea.
    Lee JG; Park MJ
    Eval Program Plann; 2020 Apr; 79():101775. PubMed ID: 31865011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In pursuit of patents: 21st century challenges.
    Blatt RJ
    J Biolaw Bus; 1998; 1(4):4-7. PubMed ID: 11657745
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent Network Analysis and Quadratic Assignment Procedures to Identify the Convergence of Robot Technologies.
    Lee WJ; Lee WK; Sohn SY
    PLoS One; 2016; 11(10):e0165091. PubMed ID: 27764196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A US perspective on technology transfer: the changing role of the university.
    Nelsen LL
    Nat Rev Mol Cell Biol; 2004 Mar; 5(3):243-7. PubMed ID: 14991004
    [No Abstract]   [Full Text] [Related]  

  • 13. Invention and business performance in the tissue-engineering industry.
    Pangarkar N; Hutmacher DW
    Tissue Eng; 2003 Dec; 9(6):1313-22. PubMed ID: 14670118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biotechnology research and generation of patents of interest to the health system].
    Plaza Gómez L; Albert Martínez A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing face of industry.
    Cyranoski D
    Nature; 2015 Dec; 528(7582):S184-6. PubMed ID: 26673026
    [No Abstract]   [Full Text] [Related]  

  • 16. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    Yu S; Sohn H; Kim HY; Kim H; Oh KH; Kim HJ; Chung H; Choi H
    PLoS Med; 2021 Jul; 18(7):e1003717. PubMed ID: 34260579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 19. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.